Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Potential cognition-enhancing agent described by Rotta

Feb. 12, 1997

Servier describes 5-HT3 agonist with additionial antagonist-like properties

Feb. 12, 1997

Cephalon and Chiron seek FDA approval for rhIGF-1

Feb. 12, 1997

Neurotrophic rotamase inhibitors described by Guilford

Feb. 12, 1997

Anticonvulsants with favorable protection indices reported by Canadian researchers

Feb. 12, 1997

Positive phase III trials results for citicoline

Feb. 11, 1997

Essential fatty acids in schizophrenia

Feb. 11, 1997

U.S. researchers report significant advance in gene therapy for hearing disorders

Feb. 11, 1997

Takeda prepares NO production inhibitors

Feb. 11, 1997

U.S. and European investigators describe agents for CNS disorders

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...